SERA
Sera Prognostics Inc
NASDAQ: SERA · HEALTHCARE · MEDICAL DEVICES
$1.99
+0.51% today
Updated 2026-04-29
Market cap
$77.93M
P/E ratio
—
P/S ratio
962.05x
EPS (TTM)
$-0.67
Dividend yield
—
52W range
$1 – $4
Volume
0.1M
Sera Prognostics Inc (SERA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-89,540.00%
ROE
-51.80%
ROA
-26.20%
Debt/equity
0.03x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $36000.00 | $-16.52M | 50.00% | -46,044.44% | -45,891.67% |
| 2020 | $25000.00 | $-19.85M | 56.00% | -71,884.00% | -79,392.00% |
| 2021 | $82000.00 | $-35.01M | 54.88% | -43,164.63% | -42,693.90% |
| 2022 | $268000.00 | $-44.19M | 27.99% | -17,034.33% | -16,487.31% |
| 2023 | $306000.00 | $-36.24M | 31.37% | -13,013.40% | -11,843.79% |
| 2024 | $77000.00 | $-32.90M | -6.49% | -47,577.92% | -42,724.68% |
| 2025 | $81000.00 | $-31.93M | -102.47% | -45,066.67% | -39,417.28% |